Clinical trials query results
From Health Canada
- Medical condition:
- MALIGNANT PLEURAL MESOTHELIOMA
- Medical condition:
- ADULT FEMALE,ADULT MALE
- Drug name:
- BAY 94-9343 (ANETUMAB RAVTANSINE) / VINORELBINE
- Protocol title:
- A RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED, PHASE II STUDY OF INTRAVENOUS ANETUMAB RAVTANSINE (BAY 94-9343) OR VINORELBINE IN PATIENTS WITH ADVANCED OR METASTATIC MALIGNANT PLEURAL MESOTHELIOMA OVEREXPRESSING MESOTHELIN AND PROGRESSED ON FIRST LINE PLATINUM/ PEMETREXED-BASED CHEMOTHERAPY
- Sponsor name:
- BAYER INC
- Date of no objection letter:
- 2015-12-04
- Control number:
- 189220
- Trial status:
- CLOSED
- Date study started:
- 2016-12-09
- Date study completed:
- 2019-07-11